Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 96

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 96
---
     |           | (1,062 | ) |     |                |
| Total capitalization            |     |                        | ‌(38,698 | ) |     |           | (1,062 | ) |     |                |

| (1) | Each $0.25 increase or decrease in the assumed initial public offering price of $     per Ordinary Share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, respectively, the amount of cash, cash equivalents and short-term deposits, total shareholders’ (deficiency) equity and total capitalization by $     million, assuming the number of Ordinary Shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of Ordinary Shares we are offering. An increase or decrease of 1.0 million in the number of Ordinary Shares we are offering would increase or decrease, respectively, the amount of cash, cash equivalents and short-term deposits, total shareholders’ (deficiency) equity and total capitalization by $     million, assuming the assumed initial public offering price per Ordinary Shares, as set forth on the cover page of this prospectus, remains the same. The pro forma as adjusted information is illustrative only, and we will adjust this information based on the actual initial public offering price and other terms of this offering determined at pricing. |

<div align='center'>59</div>

The number of the Ordinary
Shares to be issued and outstanding immediately after this offering as shown above assumes that all of the Ordinary Shares offered hereby
are sold, and is based on 1,571,752 Ordinary Shares issued and outstanding as of June 30, 2024. [After giving effect to a -for- Reverse
Split of our Ordinary Shares], this number excludes:

| ● | 66,946 Ordinary Shares issuable upon the exercise of warrants currently outstanding, at an exercise price of $38.01; |

| ● | 31,716 Ordinary Shares issuable upon the exercise of options to consultants under our incentive option plan outstanding as of such date, at an exercise price of $9.933, of which 31,716 were vested as of such date; |

| ● | 194,098 Ordinary Shares issuable upon the exercise of options to chairman of the board of directors to be issued upon the completion of this offering under